Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07821307) titled 'Opiranserin Injections PCA Regimens for Postoperative Pain' on Sept. 9.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Samsung Medical Center
Condition:
Pain, Postoperative / Acute Pain
Intervention:
Drug: VVZ-149 Injections
Drug: VVZ-149 Injections
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: July 22, 2025
Target Sample Size: 66
Countries of Recruitment:
South Korea
To know more, visit ...